Cargando…

Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin

BACKGROUND: Pain from bone metastases of breast cancer origin is treated with localized radiation. Modulating doses and schedules has shown little efficacy in improving results. Given the synergistic therapeutic effect reported for combined systemic chemotherapy with local radiation in anal, rectal,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kundel, Yulia, Nasser, Nicola J., Purim, Ofer, Yerushalmi, Rinat, Fenig, Eyal, Pfeffer, Raphael M., Stemmer, Salomon M., Rizel, Shulamith, Symon, Zvi, Kaufman, Bella, Sulkes, Aaron, Brenner, Baruch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707893/ https://www.ncbi.nlm.nih.gov/pubmed/23874586 http://dx.doi.org/10.1371/journal.pone.0068327

Ejemplares similares

Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
por: Dickman, Ram, et al.
Publicado: (2013)

Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
por: Ben-Aharon, Irit, et al.
Publicado: (2013)

Postoperative chemoradiation for resected gastric cancer - is the Macdonald Regimen Tolerable? a retrospective multi-institutional study
por: Kundel, Yulia, et al.
Publicado: (2011)

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy
por: Wasserberg, Nir, et al.
Publicado: (2014)

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016)

The association between smoking and breast cancer characteristics and outcome
por: Goldvaser, Hadar, et al.
Publicado: (2017)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
por: Brenner, Baruch, et al.
Publicado: (2016)

Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity
por: Goldvaser, Hadar, et al.
Publicado: (2017)

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014)

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using (18) F-FDG PET-CT imaging. A prospective clinical study
por: Goldberg, Natalia, et al.
Publicado: (2012)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
por: Granot, Tal, et al.
Publicado: (2016)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
por: Ben-Aharon, Irit, et al.
Publicado: (2018)

The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer
por: Kundel, Yulia, et al.
Publicado: (2023)

Doxorubicin-induced ovarian toxicity
por: Ben-Aharon, Irit, et al.
Publicado: (2010)

Cancer of the colon and rectum: Potential effects of sex-age interactions on incidence and outcome
por: Purim, Ofer, et al.
Publicado: (2013)

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
por: Landman, Yosef, et al.
Publicado: (2019)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study
por: Epelbaum, Ron, et al.
Publicado: (2015)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
por: Kundel, Yulia, et al.
Publicado: (2020)

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy
por: Stemmer, Salomon M., et al.
Publicado: (2019)

A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic solid tumors
por: Stemmer, Salomon M., et al.
Publicado: (2018)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
por: Das, Prajnan, et al.
Publicado: (2006)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
por: Ji, Jeong-Seon, et al.
Publicado: (2010)

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018)

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer
por: Zlotnik, Oran, et al.
Publicado: (2021)

Automatic localization of the prostatic urethra for image guided radiation therapy
por: Nasser, Nicola J., et al.
Publicado: (2021)

Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2021)

Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients
por: Nasser, Nicola J., et al.
Publicado: (2017)

Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan
por: Mansha, Muhammad Atif, et al.
Publicado: (2021)

Merkel cell carcinoma in lymph nodes with and without primary origin
por: Fennig, Shlomit, et al.
Publicado: (2022)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study
por: Margel, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t9ojtl6elb5mcj3dk10pcf4poe